Aptevo Therapeutics Inc. Gains 35.37%
Tue, Nov 10, 2020 at 05:30 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) shot up at $44.32, representing a gain of 35.4%. On Mon 09 Nov 20, APVO:NASDAQ touched a New 2-Week High of $32.74. The stock appeared on our News Catalysts scanner on Tue 10 Nov 20 at 01:20 PM in the 'BIOTECH' category. From Mon 26 Oct 20, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon 09 Nov 20 at $60 with a volume of 7M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 120.51%
- Summit Wireless Technologies, Inc. (WISA:NASDAQ), 70.42%
- Revlon, Inc. (REV:NYSE), 47.24%
- Trxade Group, Inc. (MEDS:NASDAQ), 41.86%
- Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 35.41%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 35.37%
- Team, Inc. (TISI:NYSE), 28.12%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 27.69%
- Teligent, Inc. (TLGT:NASDAQ), 27.3%
- Vaccinex, Inc. (VCNX:NASDAQ), 26.37%